Heavy metal burdens as a harmful substance is
becoming more and more frequent. This
possibility should always be explored when
patients present unclear symptoms. The usual
chelation treatment, particular DMPS,
necessitates the use of relatively high doses of
this harmful substance in treatments over long
periods, or intermittent therapy. For this
reason it was desirable to look for a drug to
achieve a reduced burden to excrete heavy
metals.
Often, no typical symptoms are seen in
chemical poisoning by heavy metals when
increased limits are seen in the blood. In
general, the diagnosis of a chronic heavy metal
burden belongs to the most difficult tasks in
medicine. Likewise, when a heavy metal burden is
found, the treatment should be free of side
effects, when given over a longer time period.
The intake of penicillamine, calcium-edetate,
DMPS and others is necessary for the treatment
of acute poisoning, occasionally even with high
doses. A chronic heavy metal burden,
particularly when multiple permissible limits
are recognized, but yet no toxic blood
concentration, is the therapeutic use in the
recommended doses (Dr. Daunderer) because of
possible side effects is not justified. It would
be much more meaningful to strive for a
treatment with lower side effects.
Pre-trials showed the effectiveness and no
side effects of Bio-Chelat™ when the documented
allowable limits of heavy metals in the blood
are increased.
The statistical analysis of the pre-clinical
studies showed the reliability of those
experiences that were gathered (see the summary
of the results which also demonstrate a
neutrality toward physiological minerals such as
calcium, magnesium, potassium, sodium and
selenium).
Another clinical study confirmed the results
of these pre-clinical investigations and was
able to prove that the treatment with Bio-Chelat™
leads to such a strong reduction of the heavy
metal concentration in the blood, coupled with a
slight decrease of zinc and leucocytes, and
slight increase of thrombocytes and Gamma-GT-values,
respectively. The additional confirmation
regarding the physiologic iron, magnesium,
calcium, LDH and GOT values showed that the
general burden, particular on the liver, blood,
and intestines, was missing when being treated
with Bio-Chelat™.
This is to say that the results, in regards
to both clinical studies, show the effectiveness
of the heavy metal detoxification, harmlessness
of the therapeutically used solution and allows
the subsequent analysis of Bio-Chelat™:
1. Bio-Chelat™ is useful in the treatment of
chronic heavy metal burden but should not be
used in acute poisoning because of its mild
effectiveness.
2. It is therefore not necessary to use the
prevalently used high doses of EDTA in chronic
heavy metal burdens and tolerate their side
effects. Bio-Chelat™ is a strongly diluted EDTA
substance containing other buffered substances
and is fully effective over the duration of time
used and without any side-effects during the
removal of the patient's heavy metal burden.
3. The treatment is successful even when
multiple permissible heavy metal limits in the
blood are present.
4. Contrary to typical treatments and
results, physiologic mineral concentration in
the blood of Ca, Mg, K, Na, Se or Fe were not
affected. This is of significant importance when
patients of specific age groups are treated
(kids, old people, pregnant women).
5. Clinically controlling additional
parameters can demonstrate that Bio-Chelat™,
even when used over multiple weeks (see clinical
study), doesn't place a burden on the blood,
liver or intestinal functions (see LDH results).
6. Bio-Chelat™ can be recommended, not only
because of its’ negligible food chemistry-like
concentrations, but also because of its’
complete harmlessness when used in the
elimination of chronic heavy metal burden.
No position is taken at this time on the
possible relief on the immune system by the
gentle Bio-Chelat™ treatment.